AAAAAA

   
Results: 1-8 |
Results: 8
Alterations in peripheral B cells and B cell progenitors following androgen ablation in mice
Authors: Ellis, TM Moser, MT Le, PT Flanigan, RC Kwon, ED
Citation: Tm. Ellis et al., Alterations in peripheral B cells and B cell progenitors following androgen ablation in mice, INT IMMUNOL, 13(4), 2001, pp. 553-558
T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer
Authors: Mercader, M Bodner, BK Moser, MT Kwon, PS Park, ESY Manecke, RG Ellis, TM Wojcik, EM Yang, D Flanigan, RC Waters, WB Kast, WM Kwon, ED
Citation: M. Mercader et al., T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer, P NAS US, 98(25), 2001, pp. 14565-14570
Murine six-transmembrane epithelial antigen of the prostate, prostate stemcell antigen, and prostate-specific membrane antigen: Prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate mice
Authors: Yang, DM Holt, GE Velders, MP Kwon, ED Kast, WM
Citation: Dm. Yang et al., Murine six-transmembrane epithelial antigen of the prostate, prostate stemcell antigen, and prostate-specific membrane antigen: Prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate mice, CANCER RES, 61(15), 2001, pp. 5857-5860
Peptide vaccines
Authors: Yang, D Holt, GE Rudolf, MP Velders, MP Brandt, RMP Kwon, ED Kast, WM
Citation: D. Yang et al., Peptide vaccines, MED INTEL U, 26, 2001, pp. 214-226
Clinical significance of defective dendritic cell differentiation in cancer
Authors: Almand, B Resser, JR Lindman, B Nadaf, S Clark, JI Kwon, ED Carbone, DP Gabrilovich, DI
Citation: B. Almand et al., Clinical significance of defective dendritic cell differentiation in cancer, CLIN CANC R, 6(5), 2000, pp. 1755-1766
Costimulatory wars: the tumor menace
Authors: Hurwitz, AA Kwon, ED van Elsas, A
Citation: Aa. Hurwitz et al., Costimulatory wars: the tumor menace, CURR OP IM, 12(5), 2000, pp. 589-596
Combination immunotherapy of primary prostate cancer in a transgenic mousemodel using CTLA-4 blockade
Authors: Hurwitz, AA Foster, BA Kwon, ED Truong, T Choi, EM Greenberg, NM Burg, MB Allison, JP
Citation: Aa. Hurwitz et al., Combination immunotherapy of primary prostate cancer in a transgenic mousemodel using CTLA-4 blockade, CANCER RES, 60(9), 2000, pp. 2444-2448
Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy
Authors: Kwon, ED Foster, BA Hurwitz, AA Madias, C Allison, JP Greenberg, NM Burg, MB
Citation: Ed. Kwon et al., Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy, P NAS US, 96(26), 1999, pp. 15074-15079
Risultati: 1-8 |